Literature DB >> 10734287

Measures of treatment effectiveness on tumour response and survival: a multi-state model approach.

S Chevret1, M Leporrier, C Chastang.   

Abstract

This paper proposes the application of a counting process approach in the analysis of treatment effect on tumour response and survival. It relies on the definition of two transient states between which individuals may move over time, that is, response and non-response, and of one absorbing state, death. Three models are discussed according to the underlying Markov and duration dependence assumptions, as well as a marginal modelling of repeated transitions between the two transient states. We illustrate the proposed methods with data from a randomized clinical trial assessing the effect of fludarabine in patients with advanced chronic lymphocytic leukaemia. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10734287     DOI: 10.1002/(sici)1097-0258(20000330)19:6<837::aid-sim394>3.0.co;2-3

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  3 in total

1.  Analysis of the bypass angioplasty revascularization investigation trial using a multistate model of clinical outcomes.

Authors:  Xiao Zhang; Quanlin Li; Andre Rogatko; Mourad Tighiouart; Regina M Hardison; Maria Mori Brooks; Sheryl F Kelsey; Sanjay Kaul; C Noel Bairey Merz
Journal:  Am J Cardiol       Date:  2015-02-02       Impact factor: 2.778

2.  A population-based assessment of the prognostic value of the CD19 positive lymphocyte count in B-cell chronic lymphocytic leukemia using Cox and Markov models.

Authors:  R Cailliod; C Quantin; P M Carli; V Jooste; G Le Teuff; C Binquet; M Maynadie
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Second- or third-generation tyrosine kinase inhibitors in first-line treatment of chronic myeloid leukemia in general population: Is there a real benefit?

Authors:  Jim Canet; Pascale Cony-Makhoul; Sébastien Orazio; Edouard Cornet; Xavier Troussard; Marc Maynadié; Gabriel Étienne; Alain Monnereau
Journal:  Cancer Med       Date:  2021-09-22       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.